drugset / Trial / NCT01527747

Effects of DPP-4 Inhibition on Triglycerides

NCT01527747

Phase 4 Suspended 15 enrolled Oregon Health and Science University
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this study is to test the effects of saxagliptin, a treatment for diabetes, on fasting and post-meal blood triglyceride (blood fat) levels.

Timeline

Start
2012-01
Primary completion
2024-11
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SAXAGLIPTIN ANHYDROUS Small molecule 5 mg